Cargando…

Cancer‐specific mortality of high‐risk prostate cancer after carbon‐ion radiotherapy plus long‐term androgen deprivation therapy

The treatment outcomes of patients with high‐risk localized prostate cancer (PC) after carbon‐ion radiotherapy (CIRT) combined with long‐term androgen deprivation therapy (LTADT) were analyzed, and compared with those of other treatment modalities, focusing on PC‐specific mortality (PCSM). A total o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kasuya, Goro, Ishikawa, Hitoshi, Tsuji, Hiroshi, Haruyama, Yasuo, Kobashi, Gen, Ebner, Daniel K., Akakura, Koichiro, Suzuki, Hiroyoshi, Ichikawa, Tomohiko, Shimazaki, Jun, Makishima, Hirokazu, Nomiya, Takuma, Kamada, Tadashi, Tsujii, Hirohiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715357/ https://www.ncbi.nlm.nih.gov/pubmed/28921785 http://dx.doi.org/10.1111/cas.13402

Ejemplares similares

Significant impact of biochemical recurrence on overall mortality in patients with high‐risk prostate cancer after carbon‐ion radiotherapy combined with androgen deprivation therapy
por: Kasuya, Goro, et al.
Publicado: (2016)

Updated long‐term outcomes after carbon‐ion radiotherapy for primary renal cell carcinoma
por: Kasuya, Goro, et al.
Publicado: (2018)

Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma
por: Kasuya, Goro, et al.
Publicado: (2019)

Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials
por: Kasuya, Goro, et al.
Publicado: (2017)

Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer
por: Maruyama, Katsuya, et al.
Publicado: (2017)

Up-to-date results of carbon-ion radiotherapy for prostate cancer
por: Nomiya, Takuma, et al.
Publicado: (2014)

Identification of Early Biochemical Recurrence Predictors in High-Risk Prostate Cancer Patients Treated with Carbon-Ion Radiotherapy and Androgen Deprivation Therapy
por: Utsumi, Takanobu, et al.
Publicado: (2023)

Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma
por: Yasuda, Shigeo, et al.
Publicado: (2019)

Phase I/II trial of definitive carbon ion radiotherapy for prostate cancer: evaluation of shortening of treatment period to 3 weeks
por: Nomiya, T, et al.
Publicado: (2014)

Intermittent Androgen Suppression: Estimating Parameters for Individual Patients Based on Initial PSA Data in Response to Androgen Deprivation Therapy
por: Hirata, Yoshito, et al.
Publicado: (2015)

First prospective feasibility study of carbon-ion radiotherapy using compact superconducting rotating gantry
por: Bhattacharyya, Tapesh, et al.
Publicado: (2019)

Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer
por: Hiroshima, Yuichi, et al.
Publicado: (2022)

Carbon‐ion radiotherapy for urological cancers
por: Ishikawa, Hitoshi, et al.
Publicado: (2022)

Machine-learning predicts time-series prognosis factors in metastatic prostate cancer patients treated with androgen deprivation therapy
por: Saito, Shinpei, et al.
Publicado: (2023)

Exploring the contributing factors to multiple chemical sensitivity in patients with migraine
por: Suzuki, Keisuke, et al.
Publicado: (2022)

Personalizing Androgen Suppression for Prostate Cancer Using Mathematical Modeling
por: Hirata, Yoshito, et al.
Publicado: (2018)

A Review of Update Clinical Results of Carbon Ion Radiotherapy
por: Tsujii, Hirohiko, et al.
Publicado: (2012)

Progression of Androgen‐sensitive Mouse Tumor (Shionogi Carcinoma 115) to Androgen‐insensitive Tumor after Long‐term Removal of Testosterone
por: Sato, Naohide, et al.
Publicado: (1993)

Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone Metastasis
por: Yamada, Yasutaka, et al.
Publicado: (2017)

Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer
por: Takahashi, Wataru, et al.
Publicado: (2014)

Carbon-ion radiotherapy for cholangiocarcinoma: a multi-institutional study by and the Japan carbon-ion radiation oncology study group (J-CROS)
por: Kasuya, Goro, et al.
Publicado: (2019)

The clinical relative biological effectiveness and prostate‐specific antigen kinetics of carbon‐ion radiotherapy in low‐risk prostate cancer
por: Kang, Yu‐Mei, et al.
Publicado: (2022)

Epigenetic Regulation of the KAI1 Metastasis Suppressor Gene in Human Prostate Cancer Cell Lines
por: Sekita, Nobuyuki, et al.
Publicado: (2001)

Expression of Thymidine Phosphorylase in Primary Human Renal Cell Carcinoma by ELISA Method
por: Kinsui, Hidetoshi, et al.
Publicado: (2002)

Association between hypertension and hearing impairment in health check-ups among Japanese workers: a cross-sectional study
por: Umesawa, Mitsumasa, et al.
Publicado: (2019)

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy
por: Stensland, Kristian D, et al.
Publicado: (2022)

Evolution of Carbon Ion Radiotherapy at the National Institute of Radiological Sciences in Japan
por: Mohamad, Osama, et al.
Publicado: (2018)

Carbon Ion Radiotherapy for Oligo-Recurrence in the Lung
por: Yamamoto, Naoyoshi, et al.
Publicado: (2013)

Relationships between dipstick proteinuria and risk of hearing impairment among Japanese workers: a prospective cohort study
por: Umesawa, Mitsumasa, et al.
Publicado: (2019)

Publisher Correction: A large-scale population-based epidemiological study on the prevalence of central sensitization syndromes in Japan
por: Haruyama, Yasuo, et al.
Publicado: (2021)

A large-scale population-based epidemiological study on the prevalence of central sensitization syndromes in Japan
por: Haruyama, Yasuo, et al.
Publicado: (2021)

The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment
por: Ku, Ja Yoon, et al.
Publicado: (2015)

Long‐term clinical outcomes after 12‐fractionated carbon‐ion radiotherapy for localized prostate cancer
por: Sato, Hiraku, et al.
Publicado: (2021)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Androgen Deprivation Therapy and Cardiovascular Risk
por: Mourmouris, Panagiotis, et al.
Publicado: (2012)

Metabolic effects of androgen deprivation therapy
por: Choi, See Min, et al.
Publicado: (2015)

Cardiovascular Toxicities of Androgen Deprivation Therapy
por: Challa, Azariyas A., et al.
Publicado: (2021)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Cardiovascular Toxicity of Androgen Deprivation Therapy
por: Boland, Julia, et al.
Publicado: (2021)

Association between the interval of worksite dental check-ups and dental and medical expenditures: a single-site, 12-year follow-up study in Japan
por: Ichihashi, Toru, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mchohf7p5aaml042pf3aav51ko